SBC Medical Group Holdings Inc Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2024 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
SBC Medical Group Holdings Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2024 to Q2 2025.
  • SBC Medical Group Holdings Inc Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $437K.
  • SBC Medical Group Holdings Inc annual Deferred Income Tax Expense (Benefit) for 2024 was -$14.4M, a 450% decline from 2023.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $437K +$3.4M Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $7.02M +$7.38M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q2 2024 -$2.96M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 -$361K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.